498 related articles for article (PubMed ID: 38078905)
1. Ryanodine receptor 2 inhibition reduces dispersion of cardiac repolarization, improves contractile function, and prevents sudden arrhythmic death in failing hearts.
Joshi P; Estes S; DeMazumder D; Knollmann BC; Dey S
Elife; 2023 Dec; 12():. PubMed ID: 38078905
[TBL] [Abstract][Full Text] [Related]
2. Ryanodine receptor 2 inhibition reduces dispersion of cardiac repolarization, improves contractile function and prevents sudden arrhythmic death in failing hearts.
Joshi P; Estes S; DeMazumder D; Knollmann BC; Dey S
bioRxiv; 2023 Aug; ():. PubMed ID: 37662391
[TBL] [Abstract][Full Text] [Related]
3. RyR2 inhibition with dantrolene is antiarrhythmic, prevents further pathological remodeling, and improves cardiac function in chronic ischemic heart disease.
Schmeckpeper J; Kim K; George SA; Blackwell DJ; Brennan JA; Efimov IR; Knollmann BC
J Mol Cell Cardiol; 2023 Aug; 181():67-78. PubMed ID: 37285929
[TBL] [Abstract][Full Text] [Related]
4. Phenytoin Reduces Activity of Cardiac Ryanodine Receptor 2; A Potential Mechanism for Its Cardioprotective Action.
Ashna A; van Helden DF; Dos Remedios C; Molenaar P; Laver DR
Mol Pharmacol; 2020 Apr; 97(4):250-258. PubMed ID: 32015008
[TBL] [Abstract][Full Text] [Related]
5. Mitochondrial ROS Drive Sudden Cardiac Death and Chronic Proteome Remodeling in Heart Failure.
Dey S; DeMazumder D; Sidor A; Foster DB; O'Rourke B
Circ Res; 2018 Jul; 123(3):356-371. PubMed ID: 29898892
[TBL] [Abstract][Full Text] [Related]
6. Dantrolene, a therapeutic agent for malignant hyperthermia, markedly improves the function of failing cardiomyocytes by stabilizing interdomain interactions within the ryanodine receptor.
Kobayashi S; Yano M; Suetomi T; Ono M; Tateishi H; Mochizuki M; Xu X; Uchinoumi H; Okuda S; Yamamoto T; Koseki N; Kyushiki H; Ikemoto N; Matsuzaki M
J Am Coll Cardiol; 2009 May; 53(21):1993-2005. PubMed ID: 19460614
[TBL] [Abstract][Full Text] [Related]
7. Dantrolene prevents ventricular tachycardia by stabilizing the ryanodine receptor in pressure- overload induced failing hearts.
Kajii T; Kobayashi S; Shiba S; Fujii S; Tamitani M; Kohno M; Nakamura Y; Nanno T; Kato T; Okuda S; Uchinoumi H; Oda T; Yamamoto T; Yano M
Biochem Biophys Res Commun; 2020 Jan; 521(1):57-63. PubMed ID: 31635807
[TBL] [Abstract][Full Text] [Related]
8. Redox modification of ryanodine receptors underlies calcium alternans in a canine model of sudden cardiac death.
Belevych AE; Terentyev D; Viatchenko-Karpinski S; Terentyeva R; Sridhar A; Nishijima Y; Wilson LD; Cardounel AJ; Laurita KR; Carnes CA; Billman GE; Gyorke S
Cardiovasc Res; 2009 Dec; 84(3):387-95. PubMed ID: 19617226
[TBL] [Abstract][Full Text] [Related]
9. Sarcoplasmic reticulum calcium leak contributes to arrhythmia but not to heart failure progression.
Mohamed BA; Hartmann N; Tirilomis P; Sekeres K; Li W; Neef S; Richter C; Zeisberg EM; Kattner L; Didié M; Guan K; Schmitto JD; Lehnart SE; Luther S; Voigt N; Seidler T; Sossalla S; Hasenfuss G; Toischer K
Sci Transl Med; 2018 Sep; 10(458):. PubMed ID: 30209242
[TBL] [Abstract][Full Text] [Related]
10. Implantable cardioverter defibrillators. Prophylactic use: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2005; 5(14):1-74. PubMed ID: 23074465
[TBL] [Abstract][Full Text] [Related]
11. Antiarrhythmic effects of dantrolene in human diseased cardiomyocytes.
Hartmann N; Pabel S; Herting J; Schatter F; Renner A; Gummert J; Schotola H; Danner BC; Maier LS; Frey N; Hasenfuss G; Fischer TH; Sossalla S
Heart Rhythm; 2017 Mar; 14(3):412-419. PubMed ID: 27650424
[TBL] [Abstract][Full Text] [Related]
12. RyR2-targeting therapy prevents left ventricular remodeling and ventricular tachycardia in post-infarction heart failure.
Fujii S; Kobayashi S; Chang Y; Nawata J; Yoshitomi R; Tanaka S; Kohno M; Nakamura Y; Ishiguchi H; Suetomi T; Uchinoumi H; Oda T; Okuda S; Okamura T; Yamamoto T; Yano M
J Mol Cell Cardiol; 2023 May; 178():36-50. PubMed ID: 36963751
[TBL] [Abstract][Full Text] [Related]
13. Ryanodine receptor inhibition with acute dantrolene treatment reduces arrhythmia susceptibility in human hearts.
George SA; Brennan-McLean JA; Trampel KA; Rytkin E; Faye NR; Knollmann BC; Efimov IR
Am J Physiol Heart Circ Physiol; 2023 Oct; 325(4):H720-H728. PubMed ID: 37566110
[TBL] [Abstract][Full Text] [Related]
14. Ryanodine receptor phosphorylation by calcium/calmodulin-dependent protein kinase II promotes life-threatening ventricular arrhythmias in mice with heart failure.
van Oort RJ; McCauley MD; Dixit SS; Pereira L; Yang Y; Respress JL; Wang Q; De Almeida AC; Skapura DG; Anderson ME; Bers DM; Wehrens XH
Circulation; 2010 Dec; 122(25):2669-79. PubMed ID: 21098440
[TBL] [Abstract][Full Text] [Related]
15. Dantrolene prevents arrhythmogenic Ca2+ release in heart failure.
Maxwell JT; Domeier TL; Blatter LA
Am J Physiol Heart Circ Physiol; 2012 Feb; 302(4):H953-63. PubMed ID: 22180651
[TBL] [Abstract][Full Text] [Related]
16. Oxidation of ryanodine receptor after ischemia-reperfusion increases propensity of Ca
Bovo E; Mazurek SR; Zima AV
Am J Physiol Heart Circ Physiol; 2018 Oct; 315(4):H1032-H1040. PubMed ID: 30028204
[TBL] [Abstract][Full Text] [Related]
17. Arrhythmogenesis in a catecholaminergic polymorphic ventricular tachycardia mutation that depresses ryanodine receptor function.
Zhao YT; Valdivia CR; Gurrola GB; Powers PP; Willis BC; Moss RL; Jalife J; Valdivia HH
Proc Natl Acad Sci U S A; 2015 Mar; 112(13):E1669-77. PubMed ID: 25775566
[TBL] [Abstract][Full Text] [Related]
18. Dantrolene rescues aberrant N-terminus intersubunit interactions in mutant pro-arrhythmic cardiac ryanodine receptors.
Seidel M; Thomas NL; Williams AJ; Lai FA; Zissimopoulos S
Cardiovasc Res; 2015 Jan; 105(1):118-28. PubMed ID: 25411383
[TBL] [Abstract][Full Text] [Related]
19. Redox modification of ryanodine receptors contributes to sarcoplasmic reticulum Ca2+ leak in chronic heart failure.
Terentyev D; Györke I; Belevych AE; Terentyeva R; Sridhar A; Nishijima Y; de Blanco EC; Khanna S; Sen CK; Cardounel AJ; Carnes CA; Györke S
Circ Res; 2008 Dec; 103(12):1466-72. PubMed ID: 19008475
[TBL] [Abstract][Full Text] [Related]
20. The emerging role of calmodulin regulation of RyR2 in controlling heart rhythm, the progression of heart failure and the antiarrhythmic action of dantrolene.
Walweel K; Oo YW; Laver DR
Clin Exp Pharmacol Physiol; 2017 Jan; 44(1):135-142. PubMed ID: 27626620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
